Spots Global Cancer Trial Database for locally advanced pancreatic carcinoma
Every month we try and update this database with for locally advanced pancreatic carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Quality of Life With Nutritional Supplementation in Patients With Locally Advanced/Metastatic Pancreatic Cancer. | NCT05360745 | Quality of Life Locally Advance... Metastatic Panc... | ARACOMPLEX® placebo | 18 Years - 75 Years | Fundacion para la Excelencia y la Calidad de la Oncologia | |
A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma | NCT02539537 | Pancreatic Canc... Carcinoma | Gemcitabine Folinic Acid 5-Fluoro-uracil Oxaliplatin Irinotecan L-folinic | 18 Years - | UNICANCER | |
MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial | NCT05975593 | Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Cervical Cancer Pancreas Cancer Pancreatic Canc... Cancer of the C... Cancer of the P... | 18 Years - | Washington University School of Medicine | ||
Binimetinib and Encorafenib for the Treatment of Pancreatic Cancer in Patients With a Somatic BRAF V600E Mutation | NCT04390243 | Locally Advance... Metastatic Panc... Recurrent Pancr... Stage III Pancr... Stage IV Pancre... | Binimetinib Encorafenib | 18 Years - | Academic and Community Cancer Research United | |
PANFIRE Study: Irreversible Electroporation (IRE) to Treat Locally Advanced Pancreatic Carcinoma | NCT01939665 | Locally Advance... Non-metastasize... Pancreatic Canc... | NanoKnife "Irre... | 18 Years - | Amsterdam UMC, location VUmc | |
MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial | NCT05975593 | Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Cervical Cancer Pancreas Cancer Pancreatic Canc... Cancer of the C... Cancer of the P... | 18 Years - | Washington University School of Medicine | ||
Quality of Life With Nutritional Supplementation in Patients With Locally Advanced/Metastatic Pancreatic Cancer. | NCT05360745 | Quality of Life Locally Advance... Metastatic Panc... | ARACOMPLEX® placebo | 18 Years - 75 Years | Fundacion para la Excelencia y la Calidad de la Oncologia | |
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations | NCT04550494 | Advanced Pancre... Anatomic Stage ... Anatomic Stage ... Castration-Resi... Clinical Stage ... Clinical Stage ... HER2-Positive B... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Metastatic Brea... Metastatic Gast... Metastatic Mali... Metastatic Ovar... Metastatic Panc... Metastatic Pros... Platinum-Sensit... Stage II Pancre... Stage III Ovari... Stage III Pancr... Stage III Prost... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... | Biopsy Biospecimen Col... Computed Tomogr... Magnetic Resona... Talazoparib | 18 Years - | National Cancer Institute (NCI) | |
Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study | NCT03033225 | Advanced Pancre... Locally Advance... Metastatic Panc... Pancreatic Neop... Stage II Pancre... Stage III Pancr... Stage IV Pancre... Unresectable Pa... | Endoscopic Ultr... Fluorescence Im... Photodynamic Th... Quality-of-Life... Questionnaire A... Verteporfin | 18 Years - | Mayo Clinic | |
Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer | NCT05411094 | Locally Advance... Stage II Pancre... Stage III Pancr... Unresectable Pa... | Biopsy Biospecimen Col... Diagnostic Imag... Durvalumab Olaparib Radiation Thera... | 18 Years - | National Cancer Institute (NCI) | |
Irreversible Electroporation (NanoKnife) for the Treatment of Pancreatic Adenocarcinoma | NCT03105921 | Pancreatic Aden... Interventional ... | NanoKnife | 18 Years - 75 Years | Poitiers University Hospital |